Calprotectin Stool Test: Levels and High Results

Understand what your stool inflammation marker can—and cannot—tell you, including how to read a high result on the GI-MAP™.

Editorial update: October 11, 2026 · Reviewed by Madison Ordway, FDN-P. Review history

Key facts

  • Calprotectin is an inflammation marker measured in stool, also called fecal or faecal calprotectin.
  • A high result is not a diagnosis. IBD, infections and other conditions can raise it.
  • Read your own lab’s range. Cutoffs and results from different methods are not interchangeable.

What does a calprotectin stool test measure?

Calprotectin is a protein found in immune cells, especially neutrophils. More of it can enter stool when the intestines are inflamed. A stool test measures the amount; it does not show the exact location or cause of inflammation. MedlinePlus explains how the test works.

Clinicians use fecal calprotectin alongside symptoms and other findings when considering inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. It can help assess whether symptoms that resemble irritable bowel syndrome (IBS) warrant investigation for inflammation. People with established IBD may also have repeat testing to help monitor disease activity; the result is one part of their care plan.

Calprotectin levels: why “normal” ranges differ

Results are commonly reported in micrograms per gram of stool: µg/g, also written mcg/g or ug/g. Start with the units and reference interval printed beside your result. A lab flag, a threshold used to investigate suspected IBD and a target for monitoring known IBD answer different questions.

Examples from two laboratory sources — use the range on your own report
SourcePublished reference information
DSL GI-MAP sample reportCalprotectin reference: <173 µg/g.
Mayo Clinic Laboratories CALPR assay<50 µg/g: normal; 50–120 µg/g: borderline; >120 µg/g: abnormal.

These are examples of different reporting systems, not a conversion chart. DSL’s sample report is an illustration, not your personal reference interval. Its methodology discussion describes differences between calprotectin assays and recommends using the same lab and platform for trends where possible.

Example: if your GI-MAP result is 150 µg/g and your report says <173, it falls below that report’s cutoff. It does not become a Mayo result by comparing it with Mayo’s table. Persistent symptoms still need assessment, even when a result is unflagged.

What can high calprotectin mean?

Elevated calprotectin can occur with IBD, gastrointestinal infections and other inflammatory conditions. Medicines including NSAIDs and proton pump inhibitors can affect results. An elevated value cannot identify the cause or select a treatment on its own. Mayo’s interpretation guidance also cautions that a normal result does not completely exclude IBD.

Do not assume that every high result is Crohn’s disease, cancer or a “microbiome imbalance.” Conversely, finding a microbe elsewhere on a GI-MAP report does not by itself establish why calprotectin is elevated. A clinician may need other stool tests, blood work, endoscopy or imaging, depending on the whole clinical picture.

How calprotectin fits into GI-MAP testing

The GI-MAP sample report lists calprotectin under intestinal inflammation. It is included in GI-MAP™ Standard and the + Zonulin panel. Calprotectin is a protein marker; the panel’s microbial DNA measurements answer different questions. Evidence supporting fecal calprotectin in a particular clinical setting does not validate every marker or treatment interpretation on a broad panel.

Compare it with pancreatic elastase, which assesses pancreatic enzyme output, and fecal immunochemical testing (FIT), which looks for hidden blood. These markers are not substitutes for one another or for a clinician’s diagnostic work-up.

What to do with your result

  1. Bring the full report. Include the collection date, units, lab range, symptoms and any prior results.
  2. Discuss medicines and recent illness. Do not stop prescribed or over-the-counter treatment just to change a number.
  3. Agree on the next clinical question. Ask whether a repeat calprotectin, infection testing or gastroenterology assessment is appropriate. Borderline results sometimes merit repeat testing, but timing depends on symptoms and the assay.

The World Gastroenterology Organisation emphasizes that alarm features and clinical judgment take priority. A stool marker should not delay an endoscopy that is already indicated.

Get medical help promptly for bloody or black stool, severe abdominal pain, dehydration or worsening illness. Arrange assessment for unexplained weight loss or persistent bowel changes. You do not need to wait for a GI-MAP result to seek care. NIDDK explains warning signs that need prompt care.

Frequently asked questions

What is a dangerous calprotectin level?

There is no single calprotectin number that determines whether someone needs emergency care. A result above your laboratory’s range needs clinical interpretation. Seek prompt care for blood or black stool, severe pain, dehydration or worsening illness rather than waiting for a repeat test.

Can calprotectin be high without IBD?

Yes. Infections, some medicines and other intestinal conditions can raise calprotectin. A high result is a reason to investigate; it does not prove Crohn’s disease or ulcerative colitis.

Does a normal result rule out every gut condition?

No. A low result makes active intestinal inflammation less likely in the right clinical setting, but false negatives occur. It does not diagnose IBS or rule out every infection, cancer or other cause of persistent symptoms.

Do I need another full GI-MAP to recheck calprotectin?

Not necessarily. Your clinician may order a standalone fecal calprotectin test. Ask which laboratory, method and timing will make the follow-up result useful; a broader panel is not automatically needed.

Choosing a test? First confirm which clinical question you need answered.

View the sample report Explore GI-MAP™ Standard

Review history

Reviewed by Madison Ordway, FDN-P. Review standards.

The prior version credited Madison Ordway, FDN-P, with a July 6, 2026 review. This October 11, 2026 editorial update checks the linked laboratory and clinical sources. This update has been reviewed by Madison Ordway, FDN-P.

Educational information; individual results need assessment by a qualified licensed clinician.

See your own gut markers

The GI-MAP™ panel combines microbial DNA testing with separate intestinal-health measurements. Review the sample report and shipping eligibility before ordering.

Order Your GI-MAP™ Test →
Order Your GI-MAP™ Test →